ecteinascidin 743 has been researched along with Drug-Related Side Effects and Adverse Reactions in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernard, A; Dirix, L; Herremans, C; Keung, C; Khokhar, NZ; Knoblauch, R; Machiels, JP; Parekh, TV; Phelps, C; Sharma, S; Staddon, A | 1 |
| Jahn, F; Jordan, B; Jordan, K; Kegel, T; Müller-Tidow, C; Rüssel, J | 1 |
1 review(s) available for ecteinascidin 743 and Drug-Related Side Effects and Adverse Reactions
| Article | Year |
|---|---|
Trabectedin: Supportive care strategies and safety profile.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dioxoles; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Neoplasms; Ovarian Neoplasms; Sarcoma; Tetrahydroisoquinolines; Trabectedin | 2015 |
1 trial(s) available for ecteinascidin 743 and Drug-Related Side Effects and Adverse Reactions
| Article | Year |
|---|---|
Impact of cytochrome P450 3A4 inducer and inhibitor on the pharmacokinetics of trabectedin in patients with advanced malignancies: open-label, multicenter studies.
Topics: Adult; Antineoplastic Agents; Cytochrome P-450 CYP3A; Dioxoles; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Antagonism; Drug Monitoring; Drug Screening Assays, Antitumor; Drug-Related Side Effects and Adverse Reactions; Enzyme Activators; Enzyme Inhibitors; Female; Humans; Ketoconazole; Male; Metabolic Clearance Rate; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms; Rifampin; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome | 2014 |